Our Passion for IPOs
News & Views
Largest Global IPOs
Largest US IPOs
Largest US IPOs YTD
Largest US Internet IPOs
Top First Day Returns
US IPO Stats
IPO Average Age
IPO Industry Breakdown
Offer Price Discounts
Global IPO Stats
IPOs by Region
IPO Industry Breakdown
Register for Updates
Press Contact Form
Follow us on g+
Like us on Facebook
Follow us on LinkedIn
Free iPhone App
Free Android App
IPO News Feed
IPO News Archive
New Ways to Invest in IPOs
US IPO Recap: Twitter shines in a busy but shaky 13 IPO week
Analyst IPO Blog
In the most successful billion-dollar IPO since Corvis’ 135% first-day pop in July 2000, Twitter jumped 73% on Thursday after raising $1.8 billion at $26 per share, far above its initial $17 to $20 range. Twitter’s (
) 60% gain through Friday gave it a lonely perch in a week with 12 other, mostly poorly received US IPOs. No other deal ended the week up more than 20%, and nine at least temporarily broke below their offer prices. The week also saw the first postponement since August, and one other deal was pushed back to this week. The Renaissance IPO ETF (ticker
), a measure of post-IPO returns, was flat for the week. Still, the 13 pricings were the most in a week since November 2007. The year is now second since 2000 for proceeds raised ($46.9 billion vs. 2007’s $48.7 billion) and fourth for IPOs completed (195 vs. 2004’s record 217). The
has stayed packed too, with 12 deals setting terms last week and at least 20 more IPOs expected before Thanksgiving.
Six IPOs end the week with negative returns
Although Twitter’s IPO performance was impressive, large first-day returns have become increasingly common this year. The 73% first-day gain, which would have placed near the top in any of the previous five years, was only the tenth best since September. That said, the return was unusual for a deal of Twitter’s size: Of the 20 IPOs this year that raised more than $500 million, only Twitter gained more than 25% on its first day, and the average first-day return for the rest was only 7%. Twitter's performance was largely a reflection of its long-term growth profile, which far exceeded that of all other large IPOs year-to-date. Twitter will qualify for entry into the Renaissance IPO ETF at the market’s close on November 13.
The week’s remaining deals mostly struggled. Two companies, JGWPT Holdings (
) and Mavenir Systems (
), priced five dollars below the range and still fell 8%. The best performance after Twitter’s came from LGI Homes (
), which priced two dollars below the range and gained 19%. The only other company to gain more than 10% was Barracuda Networks (
), which sells security and storage software to small businesses. Barracuda's IPO float was unusually low at 4.1 million shares (8% of all shares outstanding), and insiders bought up to 20% of the deal.
IPO pricings (week of November 4, 2013)
Deal Size ($mm)
IPO Price vs. Midpoint
Return as of 11/8
LGI Homes (
Barracuda Networks (
SMB security software
NMI Holdings (
SMB web presence
Arc Logistics (
Oil product terminals
Midcoast Energy (
Midstream energy assets
Norcraft Companies (
Avianca Holdings (
Latin American airline
Blue Capital Re (
Mavenir Systems (
JGWPT Holdings (
Payment stream purchases
Twelve small deals added to the calendar
For the second straight week, more than ten companies set terms, but most of the new deals were small, with ten seeking to raise $100 million or less. Seven of the new deals were from health care companies with under $50 million in annual revenue. Dynagas LNG Partners (
) and Navigator Holdings (
) launched the largest deals, for $250 million and $203 million, respectively; both operate liquefied gas carriers.
IPOs setting terms (week of November 4, 2013)
Deal Size ($mm)
LTM Sales ($mm)
Dynagas LNG Partners (
Navigator Holdings (
Liquefied gas carriers
Tandem Diabetes Care (
Genetically enhanced seeds
GFI Software (
SMB IT software
Oxford Immunotec Global (
Heart failure treatments
Autoimmune disease treatments
Heart disease diagnositcs
Vital Therapies (
Liver failure treatments
Chinese lottery service
Social recognition company and Chinese auto website among new IPO filers
Seven companies made initial
last week. A majority were health care companies, including Kindred Biosciences (
), a developer of pet therapeutics. The last pet therapeutics company to go public, Aratana Therapeutics (
), is up 252% since its IPO in June. Globoforce (
) filed for a $75 million IPO. It provides social recognition software that allows employees to recognize each other for positive actions and behaviors. Regonized employees accrue points that they can use for a variety of awards, including online shopping and travel. Autohome, a site for car listings and reviews in China (similar to Kelley Blue Book), filed for a $120 million IPO. The filing follows the recent IPOs of Chinese websitse Qunar.com (
) and 58.com (
), which have gained 71% and 68%, respectively.
New IPO filers (week of November 4, 2013)
Deal Size ($mm)
LTM Sales ($mm)
Chinese auto info site
Scorpio Bulkers (
Ultragenyx Pharmaceutical (
Genetic disease treatments
Social recognition software
Cara Therapeutics (
Kindred Biosciences (
IPO market snapshot
The 195 IPOs in 2013 have raised $46.9 billion and produced an average return of 28%. There have been 70 IPOs in the past 90 days, with total proceeds of $19.8 billion and an average return of 22%. The active IPO pipeline includes 101 companies looking to raise a total of $28.8 billion.
Keywords / Tickers: US IPO Market,
Recently Priced IPOs
Global IPO Volume
The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included:
IPO investment firm Renaissance Capital (www.renaissancecapital.com)
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.
As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund’s average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees.
An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.
Net Asset Value (NAV)
of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding.
is current value at which an asset or service can be bought or sold.
is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds. The
Renaissance IPO Index® (IPOUSA)
is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios.
The S&P 500® Index (SPX)
is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE. The S&P 500 index components are determined by S&P Dow Jones Indices.
Investments in the
Renaissance IPO ETF, symbol "IPO"
(the “ETF”) and the
Global IPO Fund, symbol "IPOSX"
(the “Mutual Fund”) are subject to investment risk, including possible loss of the principal amounts invested. The ETF and the Mutual Fund (the “Funds”) invest in companies that have recently completed their initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. The Funds may also be subject to information technology risk and small and mid-capitalization company risk due to a greater number of IPOs in these sectors. The Funds may hold securities in the form of Depository Receipts, REITs, Master Limited Partnerships (MLPs) which have greater risks than common shares. The strategy has high portfolio turnover and securities lending risks. ETF returns may not match the return of the respective index. The ETF is classified as a non-diversified investment company and is subject to concentration risk.
Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with information about the Funds, please visit
. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETF, 1-866-486-6645.
The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the
Renaissance IPO ETF (symbol: IPO)
Global IPO Fund (symbol: IPOSX)
, may have investments in securities of companies mentioned.
Register for Updates
Renaissance Capital LLC is an SEC-registered investment adviser.
Renaissance Capital Investments, Inc. is a
-registered broker-dealer, and member of
© 2014 Renaissance Capital LLC. All rights reserved.